Exelixis
EXEL
#1638
Rank
S$13.71 B
Marketcap
$48.99
Share price
-0.27%
Change (1 day)
59.43%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company